Impact of Metformin on the Severity and Outcomes of Acute Ischemic Stroke in Patients with Type 2 Diabetes Mellitus

Journal of Stroke and Cerebrovascular Diseases

Volumn 25, Issue 2, 2016, Pages 436-446

  Mima, Yohei ^a   Kuwashiro, Takahiro ^a   Yasaka, Masahiro ^a   Tsurusaki, Yuichiro ^a   Nakamura, Asako ^a   Wakugawa, Yoshiyuki ^a   Okada, Yasushi ^a  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Acute ischemic stroke; Acute stroke outcome; Diabetes mellitus; Metformin; Stroke severity

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INCRETIN; INSULIN; METFORMIN; SULFONYLUREA; ANTIDIABETIC AGENT;

AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DAILY LIFE ACTIVITY; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANKIN SCALE; STROKE PATIENT; COMPLICATION; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STROKE; TREATMENT OUTCOME; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STROKE; TREATMENT OUTCOME;

EID: 84959369077     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2015.10.016     Document Type: Article

References (33)

1. H. Iso, H. Imano, A. Kitamura, and et al. Type 2 diabetes and risk of non-embolic ischaemic stroke in Japanese men and women Diabetologia 47 2004 2137 2144
2. N. Sarwar, Gao P., S.R. Seshasai, and et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies Lancet 375 2010 2215 2222
3. K.K. Ray, S.R. Seshasai, S. Wijesuriya, and et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials Lancet 373 2009 1765 1772
4. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
5. Cheng Y.Y., H.B. Leu, Chen T.J., and et al. Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study J Stroke Cerebrovasc Dis 23 2014 e99 e105
6. C.G. Favilla, M.T. Mullen, M. Ali, and et al. Sulfonylurea use before stroke does not influence outcome Stroke 42 2011 710 715
7. M. Weih, N. Amberger, S. Wegener, and et al. Sulfonylurea drugs do not influence initial stroke severity and in-hospital outcome in stroke patients with diabetes Stroke 32 2001 2029 2032
8. Li J., S.E. Benashski, V.R. Venna, and et al. Effects of metformin in experimental stroke Stroke 41 2010 2645 2652
9. V.R. Venna, Li J., M.D. Hammond, and et al. Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke Eur J Neurosci 39 2014 2129 2138
10. J.C. van Swieten, P.J. Koudstaal, M.C. Visser, and et al. Interobserver agreement for the assessment of handicap in stroke patients Stroke 19 1988 604 607
11. S. Matsuo, E. Imai, M. Horio, and et al. Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 2009 982 992
12. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 33 Suppl 1 2010 S62 S69
13. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III Stroke 21 1990 637 676
14. H.P. Adams Jr, B.H. Bendixen, L.J. Kappelle, and et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 1993 35 41
15. T. Brott, H.P. Adams Jr, C.P. Olinger, and et al. Measurements of acute cerebral infarction: a clinical examination scale Stroke 20 1989 864 870
16. H.P. Adams Jr, P.H. Davis, E.C. Leira, and et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) Neurology 53 1999 126 131
17. C. Aboa-Eboule, C. Binquet, A. Jacquin, and et al. Effect of previous statin therapy on severity and outcome in ischemic stroke patients: a population-based study J Neurol 260 2013 30 37
18. D. Ni Chroinin, K. Asplund, S. Asberg, and et al. Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials Stroke 44 2013 448 456
19. S. Sacco, D. Toni, A.A. Bignamini, and et al. Effect of prior medical treatments on ischemic stroke severity and outcome Funct Neurol 26 2011 133 139
20. H.C. Diener, R.L. Sacco, S. Yusuf, and et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study Lancet Neurol 7 2008 875 884
21. B. Ovbiagele, C.S. Kidwell, S. Starkman, and et al. Angiotensin 2 type 2 receptor activity and ischemic stroke severity Neurology 65 2005 851 854
22. S. Ricci, S. Lewis, P. Sandercock, and et al. Previous use of aspirin and baseline stroke severity: an analysis of 17,850 patients in the International Stroke Trial Stroke 37 2006 1737 1740
23. J.L. Wilterdink, B. Bendixen, H.P. Adams Jr, and et al. Effect of prior aspirin use on stroke severity in the Trial of Org 10172 in Acute Stroke Treatment (TOAST) Stroke 32 2001 2836 2840
24. M. Kamouchi, T. Matsuki, J. Hata, and et al. Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the Fukuoka Stroke Registry Stroke 42 2011 2788 2794
25. D. Magkou, and K. Tziomalos Antidiabetic treatment, stroke severity and outcome World Journal of Diabetes 5 2014 84 88
26. H.S. Jorgensen, H. Nakayama, J. Reith, and et al. Stroke recurrence: predictors, severity, and prognosis. The Copenhagen Stroke Study Neurology 48 1997 891 895
27. Zou M.H., S.S. Kirkpatrick, B.J. Davis, and et al. Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species J Biol Chem 279 2004 43940 43951
28. Y. Ido, D. Carling, and N. Ruderman Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation Diabetes 51 2002 159 167
29. K. Isoda, J.L. Young, A. Zirlik, and et al. Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells Arterioscler Thromb Vasc Biol 26 2006 611 617
30. D. Kukidome, T. Nishikawa, K. Sonoda, and et al. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells Diabetes 55 2006 120 127
31. N. Ouchi, R. Shibata, and K. Walsh AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle Circ Res 96 2005 838 846
32. N. Ouslimani, J. Peynet, D. Bonnefont-Rousselot, and et al. Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells Metabolism 54 2005 829 834
33. N. Ouslimani, M. Mahrouf, J. Peynet, and et al. Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1 Metabolism 56 2007 308 313